Moderna’s stock jumps after biotech raises sales outlook
The company lifted its revenue outlook for the year, saying it now expects revenue to grow as much as 25% in 2026.
The report was published on 06 de novembro de 2026 às 09:10 by MarketWatch and is part of the World news coverage.
What other outlets are saying
- CNBC: Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction
- Barchart.com: Ahead of Moderna Earnings, Here's What Barchart Data Says Comes Next for MRNA Stock
Quick answers
Who reported this story?
It was first reported by MarketWatch on 06 de novembro de 2026 às 09:10.
What is the category?
It is filed under World news on Rio Warzone News.
